ANNOUNCEMENT

Take a look at the MedCity ENGAGE program, with expert speakers from leading organizations. Reserve your place today.

Topic: Meridian Bioscience

Meridian Bioscience gets FDA nod on new C. difficile test

Meridian Bioscience gets FDA nod on new C. difficile test

May 10, 2011 3:40 pm by | 0 Comments

Diagnostics company Meridian Bioscience (NASDAQ: VIVO) has received U.S. Food and Drug Administration clearance for a new C. difficile test.C. difficile is a bacterium that can cause symptoms ranging from ... Read more
MedCity News on ONN: Children’s test for C. Diff

MedCity News on ONN: Children’s test for C. Diff

April 12, 2011 11:37 am by | 0 Comments

MedCity News’ Brandon Glenn breaks down the recent FDA approval of Meridian Bioscience’s pediatric version of its C. difficile test on this week’s edition of Health Journal on ONN.Meridian said ... Read more
Meridian Bioscience gets FDA OK on pediatric C. difficile test

Meridian Bioscience gets FDA OK on pediatric C. difficile test

March 4, 2011 11:12 am by | 0 Comments

Diagnostics company Meridian Bioscience (NASDAQ: VIVO) has received federal regulatory clearance to begin selling a pediatric version of its C. difficile test. An earlier version of the test, which the ... Read more
Where’s swine flu when you need it? Meridian Bioscience earnings drop 32%

Where’s swine flu when you need it? Meridian Bioscience earnings drop 32%

January 20, 2011 9:20 am by | 0 Comments

Life science diagnostic testing company Meridian Bioscience had a strong 2010 as swine flu fears pushed up demand for its rapid flu tests. But without swine flu, Meridian announced a ... Read more
Twitter ‘name squatter’ victimizes Meridian Bioscience

Twitter ‘name squatter’ victimizes Meridian Bioscience

January 10, 2011 1:06 pm by | 0 Comments

It happened to diagnostic test maker Meridian Bioscience Inc. (NASDAQ:VIVO), but at least it doesn't appear to have caused any damage. Meridian was victimized by a Twitter "name squatter." That ... Read more
Meridian Bioscience’s Q4 earnings drop 40%, shares tumble

Meridian Bioscience’s Q4 earnings drop 40%, shares tumble

November 11, 2010 12:31 pm by | 0 Comments

Diagnostic test maker Meridian Bioscience Inc. (NASDAQ:VIVO) capped a "disappointing" fiscal 2010 with fourth-quarter profits that fell below Wall Street's expectations and sent its shares tumbling. ... Read more
Meridian Bioscience gets Canadian nod for rapid C. difficile test

Meridian Bioscience gets Canadian nod for rapid C. difficile test

September 30, 2010 10:04 am by | 0 Comments

Meridian Bioscience Inc. (NASDAQ:VIVO) has obtained a license to begin selling its illumigene C. difficile molecular test in Canada. ... Read more
Meridian Bioscience sees a brighter 2011

Meridian Bioscience sees a brighter 2011

September 13, 2010 12:23 pm by | 0 Comments

For fiscal 2011, Meridian expects earnings between 77 cents and 82 cents per diluted share, and sales between $165 million and $170 million. ... Read more
Meridian Bioscience buys molecular reagent maker, reports results

Meridian Bioscience buys molecular reagent maker, reports results

July 20, 2010 12:22 pm by | 0 Comments

Cincinnati, Ohio life sciences company Meridian Bioscience Inc. (NASDAQ: VIVO) has acquired the outstanding capital stock of Bioline Ltd., the London, England-based maker and distributor of molecular biology reagents, for ... Read more
Meridian Bioscience gets FDA nod for molecular C. difficile test

Meridian Bioscience gets FDA nod for molecular C. difficile test

July 13, 2010 3:02 pm by | 0 Comments

Diagnostics company Meridian Bioscience Inc. (NASDAQ: VIVO) has received the go-ahead from the Food and Drug Administration to sell its first molecular test — illumigene C. difficile.Over the years the ... Read more
Meridian Bioscience strikes agreement with Italy’s DiaSorin

Meridian Bioscience strikes agreement with Italy’s DiaSorin

July 7, 2010 7:21 pm by | 0 Comments

Meridian Bioscience Inc. (NASDAQ: VIVO) has struck an exclusive, world-wide product development and distribution agreement with an Italian diagnostics company that is likely to open doors to new customers in ... Read more
Meridian Bioscience seeks FDA approval for new bacteria test

Meridian Bioscience seeks FDA approval for new bacteria test

March 23, 2010 11:41 am by | 0 Comments

Meridian Bioscience has filed an application for federal regulatory approval of a next-generation molecular test that detects a type of bacteria that causes damage to the digestive system.Meridian’s illumigene test ... Read more
Meridian Bioscience shares rebound a bit after bad news

Meridian Bioscience shares rebound a bit after bad news

March 18, 2010 12:20 pm by | 0 Comments

Updated 4:34 p.m.Shares of Meridian Bioscience Inc. rebounded a bit Thursday–a day after the Cincinnati diagnostic test maker cut its sales and earnings outlook for the fiscal year ending in ... Read more
Night Read (Ohio): Wright State University building $22M neuroscience center

Night Read (Ohio): Wright State University building $22M neuroscience center

February 25, 2010 8:23 pm by | 0 Comments

Wright State University in Dayton plans to build a $22 million state-of-the-art center to make the university a national leader in neuroscience research, and Premier Health Partners plans to provide ... Read more
Meridian Bioscience sees molecular tests as makeover of ‘just a little kit company’ image

Meridian Bioscience sees molecular tests as makeover of ‘just a little kit company’ image

January 29, 2010 3:30 pm by | 0 Comments

Over the years, Meridian Bioscience Inc. has gotten good at making diagnostic test kits that detect bugs like C. difficile and H. pylori, both bacteria that can wreak havoc in ... Read more